header
search-icon
mobile-menu-icon search-icon

RESEARCH

Clients can browse and search the Peel Hunt research library and archive.

TRADING

A tool for our clients to submit and manage orders with Peel Hunt. 

REGISTER FOR OUR RESEARCH PORTAL

Thank you, your registration has been received.
We will be in contact with you shortly.

I'm interested in (tick all that apply)

SEARCH

PEOPLE
SERVICES
NEWS

Financial Advisory and Capital Markets Services to Corporates

Comprehensive coverage of over 420 companies

Investment ideas and execution for institutional investors

Complete UK pricing coverage and worldwide access

Our joined-up approach allows us to consistently deliver value

A wealth of experience, strong collegiate ethos underpinning our joined-up approach

Our principles define the relationship between our people, our departments and our clients

We are committed to making a difference in the communities we live and work in

An environment committed to the development of our colleagues

An internship programme for undergraduates as part of their study

We have now moved to our new offices - 100 Liverpool Street.

Our joined up approach allows us to consistently deliver value to UK corporates, global institutions and trading counterparties.

We take a long-term view to building our business – for the benefit of our clients, our people and our partners.

CORONAVIRUS

Update

READ

LATEST NEWS

26 February 2021
news

£467.9 m Recommended Cash Offer – RDI REIT

Peel Hunt is acting as sole R3 adviser, joint Financial Adviser and joint Corporate Broker to RDI REIT P.L.C. PLC on its c. £467.9 million Recommended Cash Offer by SOF-12 Cambridge BidCo Limited (which is a newly formed company owned by Starwood Funds) to be effected by means of a Scheme of Arrangement under Part X of the Isle of Man Companies Act 2006, as announced 26th February, 2021.

26 February 2021
news

£29.2m Placing, Subscription and Open Offer – Shield Therapeutics

Peel Hunt is acting as NOMAD, joint Corporate Broker and joint Bookrunner to Shield Therapeutics plc on the issue of New Ordinary Shares pursuant to a Placing (£19.9m), a Subscription (c.£5.1m) and an Open Offer (£4.2m) at a price of 30 pence per New Ordinary Share to raise gross proceeds of up to c. £29.2 million, as announced on 26th February, 2021.

26 February 2021
news

New Corporate Client – Treatt

Peel Hunt has been appointed joint Corporate Broker to Treatt plc, effective 26th February, 2021.

Our Numbers

155

Corporate clients

1154

institutional relationships
(Post MiFID II)

420+

stocks covered

14%

traded of LSE volumes (in 2019)

Recognition

1ST in Research

1ST Mid & Smallcap Broker
(as voted by corporates)

11 Analysts recognised in the 2020 Starmine Awards

Non-Executive Director Awards


Peel Hunt are founders of the annual Non-Executive Director
Awards, now in its fifteenth year. The prestigious awards
recognise the vital contribution of these guardians of corporate governance.

ABOUT US

As a business, we specialise in Investment Banking Advisory and Capital Markets Services, Research, Sales and Trading. As a partnership, it is the way we run our business that sets us apart.

 

Joined-up approach

Our partnership structure best aligns our interests with those of our clients and stakeholders. We only engage with clients as a house – investment banking, sales and research must all agree. This leads to long-term successful client relationships. We call this approach being “joined-up”.

 

Balanced business

Unlike all others, we combine the capabilities of Investment Banking Advisory and Capital Markets Services, Research and Sales with a powerful Trading platform. This allows us to provide significant liquidity to investors, better insights to our Corporate clients and stability to our business.

LONDON

Peel Hunt LLP
100 Liverpool Street
London
EC2M 2AT
United Kingdom

T: +44 (0) 20 7418 8900

info@peelhunt.com

NEW YORK

Peel Hunt Inc.
489 Fifth Avenue, 32nd Floor, 
New York
NY 10017
United States of America

T: +(1) 646-863-1400

info@us.peelhunt.com